Sage Therapeutics Announces First Quarter 2019 Financial Results and Highlights Pipeline and Business Progress

Go back to Sage Therapeutics Announces First Quarter 2019 Financial Results and Highlights Pipeline and Business Progress

SAGE Therapeutics (SAGE) Misses Q1 EPS by 12c

May 2, 2019 6:34 AM EDT

SAGE Therapeutics (NASDAQ: SAGE) reported Q1 EPS of ($3.37), $0.12 worse than the analyst estimate of ($3.25).

For earnings history and earnings-related data on SAGE Therapeutics (SAGE) click here.

... More